Dr Reddys Laboratories (RDY) Return on Capital Employed (2009)
Dr Reddys Laboratories (RDY) posted quarterly Return on Capital Employed of 18.55% for Q4 2009, down 19.78% quarter-over-quarter from 15.48% in Q3 2009.
Dr Reddys Laboratories (RDY) Return on Capital Employed (2009) Analysis & Trends
Dr Reddys Laboratories' Return on Capital Employed history runs 1 years deep, the most recent figure standing at 18.55% for Q4 2009.
- In Q4 2009, Return on Capital Employed changed N/A year-over-year to 18.55%; the TTM figure through Dec 2009 stood at 18.55% (changed N/A YoY), while the FY2026 annual figure was 12.87%, down 998.0% from the prior year.
- Return on Capital Employed for Q4 2009 stood at 18.55%, down from 15.48% in the prior quarter.
- The five-year high for Return on Capital Employed was 15.48% in Q3 2009, with the low at 18.55% in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 3.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -18.55% |
| Sep 30, 2009 | -15.48% |